What's new

Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of authorisation: 25/08/2020, Revision: 8, Status: Withdrawn

Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of authorisation: 25/08/2020, Revision: 8, Status: Withdrawn

Feb 19, 2025 - 09:55
 0
Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of authorisation: 25/08/2020, Revision: 8, Status: Withdrawn
Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of authorisation: 25/08/2020, Revision: 8, Status: Withdrawn
Read More

Tags:

Previous Article

Orphan designation: Humanised monoclonal antibody targeting B-cell maturation an...

Next Article

Glencore weighs ditching UK listing in potential blow to London Stock Exchange

Related Posts

Human medicines European public assessment report (EPAR): Bretaris Genuair, aclidinium bromide, Date of authorisation: 20/07/2012, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 25, 2025  0

Annex - National provisions for SMEs applicable to the ...

Feb 26, 2025  0

Overview of the current regulatory testing requirements for medicinal products for human use and opportunities for implementation of the 3Rs - Scientific guideline

Overview of the current regulatory testing requirements...

Feb 13, 2025  0